United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing Tyvaso DPI, a dry powder inhalation form of Tyvaso; Remunity Pump, a small, lightweight, durable pump and separate controller; RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Tyvaso PERFECT and TETON studies, which are the studies of Tyvaso in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Over the last 12 months, insiders at United Therapeutics Corporation have bought $0 and sold $193.49M worth of United Therapeutics Corporation stock.
On average, over the past 5 years, insiders at United Therapeutics Corporation have bought $0 and sold $123.74M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4 shares for transaction amount of $331 was made by PATUSKY CHRISTOPHER (director) on 2019‑06‑10.
2024-06-25 | Sale | Mesa Nilda | director | 266 0.0006% | $318.58 | $84,742 | +0.12% | |
2024-06-25 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0081% | $319.33 | $1.15M | -0.12% | |
2024-06-24 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.008% | $315.97 | $1.14M | +0.03% | |
2024-06-21 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0092% | $313.91 | $1.13M | +0.93% | |
2024-06-20 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0091% | $308.97 | $1.11M | +3.22% | |
2024-06-18 | Sale | CAUSEY CHRISTOPHER | director | 3,000 0.0075% | $304.18 | $912,539 | +3.74% | |
2024-06-18 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0089% | $303.64 | $1.09M | +3.74% | |
2024-06-17 | Sale | Olian Judy D. | director | 1,700 0.0041% | $295.43 | $502,225 | +6.39% | |
2024-06-17 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0086% | $293.51 | $1.06M | +6.39% | |
2024-06-17 | Sale | PATUSKY CHRISTOPHER | director | 2,000 0.0048% | $295.50 | $591,000 | +6.39% | |
2024-06-14 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0085% | $287.22 | $1.03M | +8.49% | |
2024-06-13 | Sale | CAUSEY CHRISTOPHER | director | 2,000 0.0046% | $281.53 | $563,055 | +7.44% | |
2024-06-13 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0084% | $285.48 | $1.03M | +7.44% | |
2024-06-12 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0083% | $281.19 | $1.01M | +9.10% | |
2024-06-11 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0081% | $275.71 | $992,558 | +10.98% | |
2024-06-10 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0081% | $273.95 | $986,204 | +9.55% | |
2024-06-07 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0082% | $277.13 | $997,658 | +8.02% | |
2024-06-06 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0081% | $276.98 | $997,124 | +5.85% | |
2024-06-05 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0081% | $277.50 | $998,995 | +4.11% | |
2024-06-04 | Sale | ROTHBLATT MARTINE A | Chairperson & CEO | 3,600 0.0081% | $273.38 | $984,150 | +5.36% |
MAHON PAUL A | EVP & GENERAL COUNSEL | 36710 0.0779% | $318.95 | 0 | 295 | |
SULLIVAN LOUIS W | director | 13060 0.0259% | $318.95 | 0 | 20 | |
Olian Judy D. | director | 5605 0.0138% | $318.95 | 0 | 12 | |
Mesa Nilda | director | 5107 0.0121% | $318.95 | 0 | 7 | |
CAUSEY CHRISTOPHER | director | 4185 0.0089% | $318.95 | 0 | 96 | |
EDGEMOND JAMES | CFO AND TREASURER | 1578 0.0036% | $318.95 | 0 | 1 | |
PATUSKY CHRISTOPHER | director | 0 0.0023% | $318.95 | 5 | 66 | <0.0001% |
ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 130 0.0003% | $318.95 | 30 | 1054 | +20.16% |
LILLY ELI & CO | 10 percent owner | 5251394 11.1747% | $318.95 | 0 | 3 | |
Thompson Tommy G | director | 9790 0.0208% | $318.95 | 0 | 13 | |
Giltner Richard | director | 3750 0.008% | $318.95 | 0 | 19 | |
BENKOWITZ MICHAEL | PRESIDENT AND COO | 2353 0.005% | $318.95 | 0 | 1 | |
JEFFS ROGER | President & Co-CEO | 1456 0.0031% | $318.95 | 0 | 274 | |
ZACCARDELLI DAVID | EVP & Chief Operating Officer | 1153 0.0025% | $318.95 | 0 | 17 | |
HADEED FRED T | EVP, Business Development | 1000 0.0021% | $318.95 | 0 | 58 | |
Ferrari John Maxim | CFO | 407 0.0009% | $318.95 | 0 | 88 | |
HICKS HENRY BRECHER III | director | 100 0.0002% | $318.95 | 0 | 1 | |
GRAY R PAUL | director | 0 0% | $318.95 | 0 | 34 | |
DWEK RAYMOND | 0 0% | $318.95 | 0 | 56 | ||
KURZWEIL RAY | director | 0 0% | $318.95 | 0 | 20 | |
MAXWELL LINDA | 0 0% | $318.95 | 0 | 1 |
BlackRock | $1.28B | 12.55 | 5.57M | +5.15% | +$62.61M | 0.03 | |
The Vanguard Group | $1.08B | 10.56 | 4.68M | +0.2% | +$2.16M | 0.02 | |
Wellington Management Company | $783.86M | 7.69 | 3.41M | -10.06% | -$87.7M | 0.13 | |
Avoro Capital Advisors Llc | $656.74M | 6.45 | 2.86M | 0% | +$0 | 7.87 | |
Renaissance Technologies | $494.29M | 4.85 | 2.15M | -0.85% | -$4.25M | 0.79 | |
State Street | $444.54M | 4.36 | 1.94M | -0.62% | -$2.77M | 0.02 | |
Fidelity Investments | $233.77M | 2.29 | 1.02M | -56.16% | -$299.42M | 0.02 | |
AQR Capital | $194.56M | 1.91 | 846,955 | +53.5% | +$67.81M | 0.33 | |
Geode Capital Management | $190.05M | 1.87 | 828,271 | +6.22% | +$11.13M | 0.02 | |
Citadel Advisors LLC | $165.24M | 1.62 | 719,311 | +823.41% | +$147.35M | 0.11 | |
Janus Henderson | $145.95M | 1.43 | 635,347 | -26.98% | -$53.93M | 0.08 | |
Fuller & Thaler Asset Management, Inc. | $131.65M | 1.29 | 573,075 | +32.93% | +$32.61M | 0.58 | |
Dimensional Fund Advisors | $129.4M | 1.27 | 563,286 | +0.24% | +$306,906.18 | 0.04 | |
Morgan Stanley | $123.18M | 1.21 | 536,208 | +16.64% | +$17.57M | 0.01 | |
LSV Asset Management | $121.64M | 1.19 | 529,519 | +40.32% | +$34.95M | 0.25 | |
AllianceBernstein | $108.72M | 1.07 | 473,285 | +354.4% | +$84.8M | 0.04 | |
Pacer Advisors Inc | $107.88M | 1.06 | 469,594 | +50.13% | +$36.02M | 0.27 | |
Nuveen | $106.88M | 1.05 | 464,874 | -5.42% | -$6.12M | 0.03 | |
BNY Mellon | $105.29M | 1.03 | 458,333 | -17.25% | -$21.95M | 0.02 | |
Invesco | $101.69M | 1 | 442,672 | +96.46% | +$49.93M | 0.02 | |
De Depot Et Placement Du Quebec Caisse | $96.5M | 0.95 | 420,058 | +49.88% | +$32.11M | 0.23 | |
Charles Schwab | $91.53M | 0.9 | 398,437 | +24.89% | +$18.24M | 0.02 | |
Northern Trust | $72.16M | 0.71 | 314,111 | -15.97% | -$13.71M | 0.01 | |
Nordea Investment Management Ab | $72.42M | 0.68 | 300,920 | +677.61% | +$63.11M | 0.09 | |
First Trust | $67.94M | 0.67 | 295,756 | +3.04% | +$2.01M | 0.07 | |
GENWORTH FINANCIAL WEALTH MANAGEMENT INC | $62.06M | 0.61 | 270,162 | -0.79% | -$494,816.88 | 0.21 | |
Palo Alto Investors Lp | $61.51M | 0.6 | 267,759 | -32.35% | -$29.41M | 6.94 | |
Legal & General | $61.35M | 0.6 | 267,065 | -4.57% | -$2.94M | 0.01 | |
Soleus Capital Management, L.P. | $59.67M | 0.59 | 259,749 | +4.13% | +$2.37M | 0.57 | |
CalPERS | $58.98M | 0.58 | 256,736 | -0.09% | -$51,227.56 | 0.04 | |
Loomis, Sayles & Company | $57.9M | 0.57 | 252,024 | -0.8% | -$464,034.77 | 0.08 | |
Eversept Partners LP | $57.69M | 0.57 | 251,135 | +1.99% | +$1.13M | 4.34 | |
Avidity Partners Management Lp | $49.85M | 0.49 | 217,000 | -8.52% | -$4.64M | 1.81 | |
Prudential Financial | $49.7M | 0.49 | 216,354 | +132.17% | +$28.29M | 0.07 | |
Schroder Investment Management Group | $49.65M | 0.49 | 216,124 | +15.05% | +$6.49M | 0.06 | |
Epoch Investment Partners Inc | $49.04M | 0.48 | 213,498 | +0.15% | +$73,280.68 | 0.22 | |
Allspring Global Investments | $42.48M | 0.42 | 184,934 | +1.95% | +$812,523.36 | 0.07 | |
Qube Research & Technologies | $42.42M | 0.42 | 184,657 | -10.03% | -$4.73M | 0.05 | |
Canada Pension Plan Investment Board | $41.53M | 0.41 | 180,800 | +567.16% | +$35.31M | 0.04 | |
Robeco Institutional Asset Management B.V. | $41.36M | 0.41 | 180,066 | +111.66% | +$21.82M | 0.09 | |
Eagle Health Investments Lp | $41.23M | 0.41 | 179,499 | +5.07% | +$1.99M | 7.86 | |
Squarepoint Ops LLC | $40.78M | 0.4 | 177,501 | +779.59% | +$36.14M | 0.16 | |
Wedge Capital Management L L P Nc | $39.18M | 0.39 | 170,549 | New | +$39.18M | 0.63 | |
Comerica | $38.11M | 0.37 | 165,911 | +5.9% | +$2.12M | 0.17 | |
Amundi | $39.1M | 0.37 | 165,030 | -12.9% | -$5.79M | 0.02 | |
Ubs Asset Management Americas Inc | $37.82M | 0.37 | 164,622 | +0.74% | +$277,272.04 | 0.01 | |
Point72 Asset Management | $37.38M | 0.37 | 162,700 | New | +$37.38M | 0.07 | |
JPMorgan Chase | $36.06M | 0.35 | 156,989 | -11.65% | -$4.76M | <0.01 | |
Krensavage Asset Management LLC | $36M | 0.35 | 156,714 | -21.98% | -$10.14M | 15.96 | |
Retirement Systems of Alabama | $33.57M | 0.33 | 146,119 | +2.7% | +$881,895.09 | 0.13 |